← Eichor
Condition: Lymphoblastic Leukemia In Children Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lymphoblastic Leukemia In Children

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Phase 1 · 1 location(s) · Guangzhou Women and Children's Medical Center · NCT06752785Newly-diagnosed Pediatric T-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06855810A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Phase 1/Phase 2 · 9 location(s) · Juventas Cell Therapy Ltd. · NCT05667506Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06764238Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Phase 1 · 16 location(s) · New York Medical College · NCT04972942Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL
Phase 1 · 3 location(s) · Chulalongkorn University · NCT07078929Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Phase 4 · 5 location(s) · St. Jude Children's Research Hospital · NCT06289673Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus H
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07366801Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA · 3 location(s) · University Hospital, Tours · NCT05792007CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
Phase 1 · 1 location(s) · National University Hospital, Singapore · NCT05043571Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Phase N/A · 5 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06131801A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymp
Phase N/A · 2 location(s) · University Children's Hospital Basel · NCT06861530The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
NA · 1 location(s) · Ege University · NCT07203742Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents Wi
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT05873322Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Phase 1 · 1 location(s) · Stanford University · NCT06408194Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06882057Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06529575Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Phase 2 · 9 location(s) · Hee Young Ju · NCT06099366Effects of Core Stabilization Exercises in Children with Acute Lymphoblastic Leukemia
NA · 1 location(s) · Karamanoğlu Mehmetbey University · NCT06794762Co-administration of CART22-65s and huCART19 for B-ALL
Phase 1/Phase 2 · 1 location(s) · Stephan Grupp MD PhD · NCT05674175Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)
Phase N/A · 1 location(s) · Jimena del Castillo · NCT04675918Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia T
Phase 1/Phase 2 · 183 location(s) · PedAL BCU, LLC · NCT04726241A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With Firs
Phase 2 · 68 location(s) · Pfizer · NCT05748171Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07278882Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
Phase N/A · 3 location(s) · French Africa Pediatric Oncology Group · NCT04794296Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
Phase 1 · 1 location(s) · Belarusian Research Center for Pediatric Oncology, Hematolog · NCT05333302Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
Phase N/A · 1 location(s) · Anhui Provincial Children's Hospital · NCT06756022Bright Ideas - CIN Feasibility Study
NA · 4 location(s) · The Hospital for Sick Children · NCT04929899Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Phase 2 · 4 location(s) · St. Jude Children's Research Hospital · NCT06390319
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.